PMG
ProVise Management Group’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-14,000
| Closed | -$98K | – | 318 |
|
|
2022
Q2 | $98K | Sell |
14,000
-5,000
| -26% | -$35K | 0.01% | 321 |
|
|
2022
Q1 | $158K | Hold |
19,000
| – | – | 0.01% | 363 |
|
|
2021
Q4 | $129K | Hold |
19,000
| – | – | 0.01% | 386 |
|
|
2021
Q3 | $101K | Hold |
19,000
| – | – | 0.01% | 371 |
|
|
2021
Q2 | $109K | Hold |
19,000
| – | – | 0.01% | 383 |
|
|
2021
Q1 | $88K | Hold |
19,000
| – | – | 0.01% | 349 |
|
|
2020
Q4 | $63K | Hold |
19,000
| – | – | 0.01% | 339 |
|
|
2020
Q3 | $56K | Hold |
19,000
| – | – | 0.01% | 288 |
|
|
2020
Q2 | $88K | Hold |
19,000
| – | – | 0.01% | 273 |
|
|
2020
Q1 | $73K | Hold |
19,000
| – | – | 0.01% | 260 |
|
|
2019
Q4 | $71K | Hold |
19,000
| – | – | 0.01% | 305 |
|
|
2019
Q3 | $101K | Hold |
19,000
| – | – | 0.01% | 303 |
|
|
2019
Q2 | $73K | Hold |
19,000
| – | – | 0.01% | 310 |
|
|
2019
Q1 | $97K | Hold |
19,000
| – | – | 0.01% | 301 |
|
|
2018
Q4 | $36K | Hold |
19,000
| – | – | 0.01% | 300 |
|
|
2018
Q3 | $72K | Hold |
19,000
| – | – | 0.01% | 322 |
|
|
2018
Q2 | $59 | Hold |
19,000
| – | – | ﹤0.01% | 320 |
|
|
2018
Q1 | $45K | Hold |
19,000
| – | – | 0.01% | 300 |
|
|
2017
Q4 | $74K | Hold |
19,000
| – | – | 0.01% | 315 |
|
|
2017
Q3 | $48K | Hold |
19,000
| – | – | 0.01% | 314 |
|
|
2017
Q2 | $52K | Hold |
19,000
| – | – | 0.01% | 323 |
|
|
2017
Q1 | $37K | Hold |
19,000
| – | – | 0.01% | 319 |
|
|
2016
Q4 | $20K | Hold |
19,000
| – | – | ﹤0.01% | 321 |
|
|
2016
Q3 | $21K | Hold |
19,000
| – | – | ﹤0.01% | 320 |
|
|
2016
Q2 | $13K | Buy |
+19,000
| New | +$13K | ﹤0.01% | 301 |
|